By Route of Administration: Parenteral dominates, Oral growing fastest Parenteral (subcutaneous injection) delivery held the dominant route of administration position in 2025, reflecting that all high-dose, high-efficacy GLP-1 formulations currently approved for obesity management require injection for the delivery of drug quantities sufficient to achieve therapeutic plasma concentrations
Reapply sunscreen every 2 hours with heavy sweating or swimming
Oxidative stress is considered as an imbalance between pro- and antioxidant species, which results in molecular and cellular damage
Secondary analysis of multiple general population studies, including AMPLITUDE-O, SELECT, ELIXA, SURPASS, and LEADER, demonstrated significant improvements in various surrogate kidney outcomes, including slowing eGFR decline, proteinuria reduction, and decreased progression to end-stage renal disease